[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sang-Hwan Ji\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100560276",false,"NCT06575036","Sugammadex Dose Finding Under Two Years Old","Reversal of Rocuronium-induced Neuromuscular Blockade by Sugammadex in Children Younger Than 2 Years Old: a Prospective Dose Finding Study","Inclusion Criteria:\n\n* Childern younger than 2 years old who are scheduled to undergo surgery under general anesthesia\n* American Society of Anesthesiologists Physical Status 1 or 2\n\nExclusion Criteria:\n\n* History of hypersensitivity to rocuronium or any anesthetics\n* Presence of cardiovascular or genitourinary disease\n* Presence of severe renal dysfunction or in need of dialysis\n* Presence of severe hepatic dysfunction or coagualtion disorder\n* Current state of administration of neuromuscular blocking agent on admission to operating room\n* Concurrent use of any medications that affect the activity of neuromuscular blocking agents\n* History of malignant hyperthermia\n* Refusal to enroll in the study by one or more parents\n* Presence of any other reasons that investigator regards inappropriate to enroll in the study.","ALL","23 Months",{"count":18,"type":19},33,"ESTIMATED","INTERVENTIONAL",[22],"PHASE2","This is a prospective dose-finding study of sugammadex for conventional reversal of rocuronium-induced neuromuscular blockade in children under two years of age. This study will explore 50% effective dose and 95% effective dose of sugammadex for reversal of neuromuscular blockade in less than two minutes under biased coin up-and-down method.",[25],"Neuromuscular Blockade",[27,28,29],"Sugammadex","Children","Dose-finding study","NOT_YET_RECRUITING","2024-08-27",{"date":33,"type":34},"2024-08-29","ACTUAL",{"date":36,"type":19},"2024-09-15",{"date":38,"type":19},"2025-05-31",{"name":40,"class":41},"Sang-Hwan Ji","OTHER",""]